Synergism in the repression of COX-2- and TNFα-induction in platelet activating factor-stressed human neural cells

Neuroscience Letters

Volumn 426, Issue 1, 2007, Pages 59-63

  Boetkjaer, Anja ^a   Boedker, Merete ^a   Cui, Jian Guo ^b   Zhao, Yuhai ^b   Lukiw, Walter J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Budesonide epimer R; Cyclooxygenase 2; Human neural cells; LAU 0901; Neuroinflammation; Oxidative stress; Phenyl butyl nitrone; Prostaglandin E2; TNF

Indexed keywords

2,4,6 TRIMETHYL 1,4 DIHYDRO 3,5 PYRIDINEDICARBOXYLIC ACID 2 (3,4 DICHLOROPHENOXY)ETHYL BIS(MORPHOLINOMETHYL)METHYL ESTER; BUDESONIDE; CYCLOOXYGENASE 2; GLUCOCORTICOID; NITRONE DERIVATIVE; PHENYLBUTYLNITRONE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GENE ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; NERVE CELL; NERVE CELL CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CELL SURVIVAL; CELLS, CULTURED; CYCLIC N-OXIDES; CYCLOOXYGENASE 2; DIHYDROPYRIDINES; DINOPROSTONE; DRUG SYNERGISM; ENCEPHALITIS; GENE EXPRESSION; HUMANS; NEURONS; OXIDATIVE STRESS; PLATELET ACTIVATING FACTOR; SIGNAL TRANSDUCTION; STRESS; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 34548862329     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.08.050     Document Type: Article

References (26)

1. Aihara M., Ishii S., Kume K., and Shimizu T. Interactions between neuron and microglia mediated by platelet-activating factor. Genes Cells 5 (2000) 397-406
2. Bazan N.G., and Lukiw W.J. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J. Biol. Chem. 277 (2002) 30359-30367
3. Bazan N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32 (2005) 89-103
4. Boedker M., Boetkjaer A., Bazan N.G., Cui J.G., Zhao Y., Pelaez R.P., and Lukiw W.J. Budesonide epimer R, LAU-8080 and phenyl butyl nitrone synergistically repress cyclooxygenase-2 induction in [IL-1beta + Abeta42]-stressed human neural cells. Neurosci. Lett. 380 (2005) 176-180
5. Butterfield D.A., Koppal T., Howard B., Subramaniam R., Hall N., Hensley K., Yatin S., Allen K., Aksenov M., Aksenova M., and Carney J. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Ann. N.Y. Acad. Sci. 854 (1998) 448-462
6. Cortina M.S., Gordon W.C., Lukiw W.J., and Bazan N.G. Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria. Exp. Eye Res. 81 (2005) 742-750
7. Cui J.G., Hill J.M., Zhao Y., and Lukiw W.J. Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease. Neuroreport 18 (2007) 115-119
8. Djaldetti R., Lev N., and Melamed E. Neuroprotection in progressive brain disorders. Isr. Med. Assoc. J. 5 (2003) 576-580
9. Esquenazi S., He J., Bazan H.E., and Bazan N.G. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J. Cataract Refract. Surg. 30 (2004) 884-891
10. Fehrenbacher J.C., Burkey T.H., Nicol G.D., and Vasko M.R. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain 113 (2005) 113-122
11. He J., and Bazan H.E. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Invest. Ophthalmol. Vis. Sci. 47 (2006) 883-891
12. Higai K., Ishihara S., and Matsumoto K. NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol. Pharm. Bull. 29 (2006) 2372-2377
13. Lin S., Rhodes P.G., Lei M., Zhang F., and Cai Z. alpha-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res. 1007 (2004) 132-141
14. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., Serhan C.N., and Bazan N.G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115 (2005) 2774-2783
15. Lukiw W.J., and Bazan N.G. Survival signaling in Alzheimer's disease. Biochem. Soc. Trans. 34 (2006) 1277-1282
16. Lukiw W.J., Pelaez R.P., Martinez J., and Bazan N.G. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3914-3919
17. Ohmori T., Hirashima Y., Kurimoto M., Endo S., and Takaku A. In vitro hypoxia of cortical and hippocampal CA1 neurons: glutamate, nitric oxide, and platelet activating factor participate in the mechanism of selective neural death in CA1 neurons. Brain Res. 743 (1996) 109-115
18. Pedersen S., Steffensen G., Ekman I., Tonnesson M., and Borga O. Pharmacokinetics of budesonide. Eur. J. Clin. Pharmacol. 31 (1987) 579-582
19. Quadros A., Patel N., Crescentini R., Crawford F., Paris D., and Mullan M. Increased TNFalpha production and COX-2 activity in organotypic brain slice cultures from APPsw transgenic mice. Neurosci. Lett. 353 (2003) 66-68
20. Rossi D., Brambilla L., Valori C.F., Crugnola A., Giaccone G., Capobianco R., Mangieri M., Kingston A.E., Bloc A., Bezzi P., and Volterra A. Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 280 (2005) 42088-42096
21. Tong N., Sanchez J.F., Maggirwar S.B., Ramirez S.H., Guo H., Dewhurst S., and Gelbard H.A. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur. J. Neurosci. 13 (2001) 1913-1922
22. Townsend K.P., and Pratico D. Novel therapeutic opportunities for Alzheimer's disease. FASEB J. 19 (2005) 1592-1601
23. Xu Y., and Tao Y.X. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. Neuroreport 15 (2004) 263-266
24. Yao Y., Chinnici C., Tang H., Trojanowski J.Q., Lee V.M.Y., and Praticò D. Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis. J. Neuroinflammat. 1 (2004) 21-25
25. Zador Z., Benyo Z., Lacza T., Hortobagyi Sr. T., Harkany T., and Hortobagyi T. Neuroprotection in brain ischemia. Ideggyogy Sz. 57 (2004) 81-93
26. Zhu P., DeCoster M.A., and Bazan N.G. Interplay among platelet-activating factor, oxidative stress, and metabotropic glutamate receptors modulates neuronal survival. J. Neurosci. Res. 77 (2004) 525-531